TABLE 2.

Characteristics of OXA-48 harboring K. pneumoniae isolates.

Isolate			Genetic support of OXA-48			MIC (mg/L)
Isolatea	ST (Pasteur)	Specimen	Transposon	Plasmid size	IncL	CTX	CAZ	ETP	IMP	MEM	CIP
KP659	15	Stool	Tn1999.2	63 kb	+	>256	32	>32	0.5	2	>32
KP920	16	Wound swab	Tn1999.2	63 kb	+	>256	>256	>32	>32	>32	>32
KP980	16	Rectal swab	Tn1999.2	63 kb	+	>256H	16	>32	2	2	>32
KP1151	15	Rectal swab	Tn1999.2	63 kb	+	>256	>256	>32	>32	>32	>32
KP1664	16	Throat swab	Tn1999.2	63 kb	+	256H	64	32	32	32	>32
KP1673	101	Urine	Tn1999.2	63 kb	+	>256	>256	>32	32	>32	>32
KP1696	377	Skin swab	invTn1999.2	63 kb	+	>256	>256	3	1	1	>32
KP1766	1658	Skin swab	invTn1999.2	63 kb	+	>256	>256	>32	16	32	>32
KP1982	377	Wound swab	Tn1999.2	63 kb	+	>256	>256	32	8	16	>32
KP2255	437	Rectal swab	invTn1999.2	63 kb	+	>256	128	32	32	32	>32
KP2451	392	Rectal swab	Tn1999.2	63 kb	+	>256	>256	2	16	4	>32
KP2540	392	Rectal swab	invTn1999.2	63 kb	+	64	128	2	4	2	> 32
KP2575	3384	Rectal swab	Tn1999	63 kb	+	4	2	>32	8	8	0.06
KP2670	101	Tracheal secretion	Tn1999	63 kb	+	0.5	0.25	2	2	1	0.03
KP2746	101	Liver biopsy	invTn1999.2	63 kb	+	2	0.5	16	8	4	0.03
KP3379	307	Urine	Tn1999.2	63 kb	+	2	1	4	2	4	16
KP3907	307	Stool	Tn1999.2	63 kb	+	>256	32	>32	2	1	>32
KP12536	3385	Tracheal secretion	Tn1999.2	63 kb	+	0.5	0.25	16	2	4	0.03
KP12883	323	Urine	invTn1999.2	63 kb	+	0.5	0.25	1	8	1	>32
KP13815	11	Wound swab	Tn1999.2	63 kb	+	>256	>256	2	4	2	>32

H, heteroresistance; CTX, cefotaxime; CAZ, ceftazidime; ETP, ertapenem; IMP, imipenem; MEM, meropenem; CIP, ciprofloxacin; ^aIsolates which were further assessed in virulence assays are highlighted in bold.